The study of platelet aggregation in whole blood [proceedings].

No abstract is available for this paper.

• Publication year

  1979

• Venue

  British Journal of Pharmacology

• Publication date

  1979-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 454976PMCID PMC2043811
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The 'electronic platelet aggregometer' [proceedings].

  1979cited by this paper
• In vivo method for quantitation of anti-platelet potency of drugs

  1978cited by this paper
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

  1976cited by this paper
• Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

  1975cited by this paper

• Pneumatic tube system transport does not alter platelet function in optical and whole blood aggregometry, prothrombin time, activated partial thromboplastin time, platelet count and fibrinogen in patients on anti-platelet drug therapy

  2017cites this paper
• IgM-Enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis: A Before-After Cohort Study

  2016cites this paper
• Point-of-Care Platelet Function Tests

  2015cites this paper
• Assessment of hemostatic changes after initiation of continuous venovenous hemodialysis.

  2015cites this paper
• Multiple Electrode Aggregometry for the Assessment of Acquired Platelet Dysfunctions during Extracorporeal Circulation

  2014cites this paper
• Studies investigating the mechanisms of the cardioprotective effects of cannabidiol

  2014cites this paper
• Einfluss der akuten normovolämischen Hämodilution auf die primäre Hämostase

  2014cites this paper
• Comparison of heparin vs . lepirudin anticoagulated tubes for the assessment of ASS-induced platelet dysfunction using the Multiplate device

  2013cites this paper
• Effects of blood pressure and the renin‐angiotensin system on platelet activation in type 2 diabetes

  2010cites this paper
• Collagen-induced p38 MAP kinase activation is a biomarker of platelet hyper-aggregation in patients with diabetes mellitus.

  2009cites this paper
• Activated platelet profile and albuminuria Correlation between albuminuria and spontaneous platelet micro-aggregate formation in type 2 diabetic patients Running title: Activated platelet profile and albuminuria

  2009cites this paper
• Correlation Between Albuminuria and Spontaneous Platelet Microaggregate Formation in Type 2 Diabetic Patients

  2009cites this paper
• Raloxifene-induced acceleration of platelet aggregation.

  2008cites this paper
• Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats.

  2006cites this paper
• P2Y12 receptors play a significant role in the development of platelet microaggregation in patients with diabetes.

  2005cites this paper
• Lack of α2-Antiplasmin Enhances ADP Induced Platelet Micro-Aggregation through the Presence of Excess Active Plasmin in Mice

  2002cites this paper
• Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates

  1999cites this paper